C12Y 106/05003
Nadh dehydrogenase
Official title: NADH dehydrogenase (ubiquinone) (1.6.5.3)
C12Y106/05003 (Nadh dehydrogenase) appears on 11 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 12
- Assignees
- 12
- Inventors
- 32
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Artificial organelles for enzymatic cofactor reduction1 Jul 2025US 12,344,878 B2Ensovi, Inc.
- Artificial organelles for enzymatic cofactor reduction14 May 2024US 11,981,948 B2Ensovi, Inc.
- Artificial organelles for enzymatic cofactor reduction27 Dec 2022US 11,535,880 B2Ensovi, Inc.
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof12 Oct 2021US 11,141,456 B2Stealth BioTherapeutics Inc.
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof3 Mar 2020US 10,576,124 B2Stealth BioTherapeutics Inc.
- Artificial organelles for enzymatic cofactor reduction29 Feb 2024US 2024/0068003 A1Ensovi, Inc.
- Artificial organelles for enzymatic cofactor reduction6 Jul 2023US 2023/0212632 A1Ensovi, Inc.
- Ndufs2 subunit knockout human cell line22 Sep 2022US 2022/0299500 A1Virginia Tech Intellectual Properties, Inc.
- Cell-Free Compositions for ATP Regeneration and Uses Thereof12 May 2022US 2022/0145282 A1Biocheminsights, Inc.
- Artificial organelles for enzymatic cofactor reduction15 Jul 2021US 2021/0214762 A1Ensovi, Inc.
Most cited
By later US patents
- Acid-tolerant yeast cell, method of producing organic acid using the same, and method of producing the yeast cell1US 10,053,714 B2Samsung Electronics Co., Ltd. · 2018
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 10,576,124 B2Stealth BioTherapeutics Inc. · 2020
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 11,141,456 B2Stealth BioTherapeutics Inc. · 2021
- Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease1US 8,530,180 B2Chiesi Farmaceutici S.P. A. · 2013